跳至主要内容
临床试验/NCT01125150
NCT01125150已完成不适用

Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia

Henry Ford Health System1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2009年2月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1

研究概览

简要总结

Acanthosis Nigricans is skin disease that associated with hyperinsulinemia. Clinical is velvety hyperpigmented plaques on neck, axilla, groin. If hyperinsulinemia is improved by treated with oral metformin and/ or diet control, acanthosis nigricans would be improved as well. Hyperpigmented plaques will be changed. We assess objective measurement by using spectroscopic and colorimetric analysis.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
11 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must have an elevated fasting insulin level, suggesting they are in an insulin resistant state.
  • Subjects must carry a diagnosis of acanthosis nigricans, which will be verified by a Dermatologist before entry into the study. If necessary, a small 4mm punch biopsy may be taken to document dermatopathology consistent with acanthosis nigricans.
  • Subjects must be willing and able to undergo treatment with Metformin, including initial referral and follow up.
  • Agree to abide by the investigator's guidelines
  • Be able to understand the requirements of the study, the risks involved and are able to sign the informed consent form
  • Agree to follow and undergo all study-related procedures

排除标准

  • Subjects with Type 1 Diabetes are excluded because of their naturally insulin-deficient, rather than hyper-insulinemic, states.
  • Women who are lactating, pregnant, or planning to become pregnant.
  • Any reason the investigator feels the patient should not participate in the study.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Iltefat Hamzavi

Dermatologist

Henry Ford Health System

研究点 (1)

Loading locations...

相似试验